Differential antimicrobial susceptibilities of Granulicatella adiacens and Abiotrophia defectiva

Ammara Mushtaq, Kerryl E. Greenwood-Quaintance, Nicolynn C. Cole, Peggy C. Kohner, Sherry M. Ihde, Gregory J. Strand, Lance W. Harper, Abinash Virk, Robin Patel

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


MICs of 25 Abiotrophia defectiva and 109 Granulicatella adiacens isolates were determined by broth microdilution. Using CLSI breakpoints, the susceptibilities of A. defectiva and G. adiacens isolates were, respectively, 24% and 34% to penicillin, 92% and 22% to ceftriaxone, 48% and 3% to cefepime, 72% and 87% to meropenem, 92% and 10% to cefotaxime, 100% and 97% to levofloxacin, 92% and 80% to clindamycin, and 24% and 50% to erythromycin. All isolates were susceptible to vancomycin. In the penicillin-susceptible subgroup, all A. defectiva isolates were susceptible to ceftriaxone; however, 62% of G. adiacens isolates were ceftriaxone nonsusceptible.

Original languageEnglish (US)
Pages (from-to)5036-5039
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Issue number8
StatePublished - Aug 2016

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'Differential antimicrobial susceptibilities of Granulicatella adiacens and Abiotrophia defectiva'. Together they form a unique fingerprint.

Cite this